Association of Pertuzumab, Trastuzumab, and Docetaxel Combination Therapy With Overall Survival in Patients With Metastatic Breast Cancer

This cohort study compares the findings of combined pertuzumab, trastuzumab, and docetaxel therapy in women with metastatic breast cancer with those in the CLEOPATRA trial.

Detalles Bibliográficos
Autores principales: Ramagopalan, Sreeram V., Pisoni, Riccardo, Rathore, Lokendra Singh, Ray, Joshua, Sammon, Cormac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807287/
https://www.ncbi.nlm.nih.gov/pubmed/33439261
http://dx.doi.org/10.1001/jamanetworkopen.2020.27764
_version_ 1783636708918558720
author Ramagopalan, Sreeram V.
Pisoni, Riccardo
Rathore, Lokendra Singh
Ray, Joshua
Sammon, Cormac
author_facet Ramagopalan, Sreeram V.
Pisoni, Riccardo
Rathore, Lokendra Singh
Ray, Joshua
Sammon, Cormac
author_sort Ramagopalan, Sreeram V.
collection PubMed
description This cohort study compares the findings of combined pertuzumab, trastuzumab, and docetaxel therapy in women with metastatic breast cancer with those in the CLEOPATRA trial.
format Online
Article
Text
id pubmed-7807287
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-78072872021-01-21 Association of Pertuzumab, Trastuzumab, and Docetaxel Combination Therapy With Overall Survival in Patients With Metastatic Breast Cancer Ramagopalan, Sreeram V. Pisoni, Riccardo Rathore, Lokendra Singh Ray, Joshua Sammon, Cormac JAMA Netw Open Research Letter This cohort study compares the findings of combined pertuzumab, trastuzumab, and docetaxel therapy in women with metastatic breast cancer with those in the CLEOPATRA trial. American Medical Association 2021-01-13 /pmc/articles/PMC7807287/ /pubmed/33439261 http://dx.doi.org/10.1001/jamanetworkopen.2020.27764 Text en Copyright 2021 Ramagopalan SV et al. JAMA Network Open. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the CC-BY-NC-ND License.
spellingShingle Research Letter
Ramagopalan, Sreeram V.
Pisoni, Riccardo
Rathore, Lokendra Singh
Ray, Joshua
Sammon, Cormac
Association of Pertuzumab, Trastuzumab, and Docetaxel Combination Therapy With Overall Survival in Patients With Metastatic Breast Cancer
title Association of Pertuzumab, Trastuzumab, and Docetaxel Combination Therapy With Overall Survival in Patients With Metastatic Breast Cancer
title_full Association of Pertuzumab, Trastuzumab, and Docetaxel Combination Therapy With Overall Survival in Patients With Metastatic Breast Cancer
title_fullStr Association of Pertuzumab, Trastuzumab, and Docetaxel Combination Therapy With Overall Survival in Patients With Metastatic Breast Cancer
title_full_unstemmed Association of Pertuzumab, Trastuzumab, and Docetaxel Combination Therapy With Overall Survival in Patients With Metastatic Breast Cancer
title_short Association of Pertuzumab, Trastuzumab, and Docetaxel Combination Therapy With Overall Survival in Patients With Metastatic Breast Cancer
title_sort association of pertuzumab, trastuzumab, and docetaxel combination therapy with overall survival in patients with metastatic breast cancer
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807287/
https://www.ncbi.nlm.nih.gov/pubmed/33439261
http://dx.doi.org/10.1001/jamanetworkopen.2020.27764
work_keys_str_mv AT ramagopalansreeramv associationofpertuzumabtrastuzumabanddocetaxelcombinationtherapywithoverallsurvivalinpatientswithmetastaticbreastcancer
AT pisoniriccardo associationofpertuzumabtrastuzumabanddocetaxelcombinationtherapywithoverallsurvivalinpatientswithmetastaticbreastcancer
AT rathorelokendrasingh associationofpertuzumabtrastuzumabanddocetaxelcombinationtherapywithoverallsurvivalinpatientswithmetastaticbreastcancer
AT rayjoshua associationofpertuzumabtrastuzumabanddocetaxelcombinationtherapywithoverallsurvivalinpatientswithmetastaticbreastcancer
AT sammoncormac associationofpertuzumabtrastuzumabanddocetaxelcombinationtherapywithoverallsurvivalinpatientswithmetastaticbreastcancer

Ejemplares similares